Criscuoli (2004) |
42 pts with severe colitis |
HE-ICH on rectal biopsy + antigenemia pp65 |
prospective |
21% |
Kishore (2004) |
63 pts with severe colitis (36 steroid resistant) |
Serology-HE and qualitative PCR |
prospective |
16% 22% |
Wada (2003) |
47 pts with severe colitis |
Antigenemia |
prospective |
34% |
de Saussure (2004) |
64 pts with active colitis |
Serology-viremia-antigenemia- HE-ICH |
prospective |
1.5%-6% |
Vega (1999) |
267 active colitis |
HE-ICH |
retrospective |
3% |
Pofelski (2005) |
48 pts severe colitis |
Quantitative PCR on colonic biopsies |
retrospective/ prospective |
38% 60% |
Kambham (2004) |
40 pts steroid resistant (25 operated on for colectomy) |
HE-ICH |
retrospective |
Overall 25% Operated on pts 24% |
Papadakis (2001) |
1895 steroid resistant pts |
HE |
retrospective |
0.5% |
Cottone (2001) |
19 Steroid resistant pts |
HE-ICH on rectal biopsy + antigenemia pp65 |
prospective |
36% |
Maconi (2005) |
77 pts operated on for colectomy |
HE-ICH on surgical specimen |
prospective |
22% overall 27% steroid resistant |
Takahashi (2004) |
69 surgical specimen of IBD pts |
HE-ICH on biopsy and surgical specimen |
retrospective |
11.5% |
Alcalà (2000) |
39 pts operated on for colectomy |
HE + ICH |
retrospective |
18% |
Eire-Brook (1986) |
26 pts operated on for colectomy |
Light and electron microscopy- ICH |
retrospective |
11.5% |
Cooper (1977) |
46 pts operated on for colectomy |
HE |
retrospective |
13% |
Rahbar (2003) |
23 pts with IBD (13 UC-10 CD) |
ICH+ in situ hybridization |
prospective |
92/100% |
Wakefield (1992) |
50 pts with IBD (29 CD-21 UC) |
qualitative PCR |
prospective |
66/81% |